NENCY SANGANI: Open Payments
NPI 1952089062 · FOXBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,931 in 175 payments from 38 companies in 2025. Trend: 2023 $365 · 2024 $2,314 · 2025 $3,931
Food & beverage: $3,931
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 39 | $963 |
| ABBVIE INC. | 23 | $447 |
| SK Life Science, Inc. | 11 | $321 |
| Lundbeck LLC | 16 | $280 |
| Biogen, Inc. | 9 | $193 |
| Eisai Inc. | 8 | $186 |
| Alexion Pharmaceuticals, Inc. | 8 | $160 |
| TG Therapeutics, Inc. | 2 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Mallinckrodt Hospital Products Inc. | 4 | $86 |
Products named: QULIPTA, VYEPTI, Leqembi, TYSABRI, ULTOMIRIS, BRIUMVI, KESIMPTA, Mavenclad.
Industry payments across MA — which companies pay providers there.
